🎗️ OncologyInjection (IV)
Kymriah
Tisagenlecleucel
CD19-directed CAR T-cell therapy for relapsed/refractory B-cell ALL and large B-cell lymphoma.
Form
Injection (IV)
Uses
2
Side effects
5
Category
Oncology
01
What is Kymriah used for?
- B-cell acute lymphoblastic leukemia (pediatric)
- Relapsed/refractory large B-cell lymphoma
02
Tisagenlecleucel side effects
Common side effects of Tisagenlecleucel include:
Cytokine release syndrome
Neurotoxicity
Infections
Cytopenias
Cardiac arrhythmia
CommonModerateLess common
03
Tisagenlecleucel warnings & precautions
- Black box: CRS and neurological toxicities. Only at certified centers
- REMS required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Kymriah in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.